These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 16368745

  • 1. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P, Jonard S, Robert Y, Dewailly D.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):941-5. PubMed ID: 16368745
    [Abstract] [Full Text] [Related]

  • 2. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 3. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
    Köninger A, Koch L, Edimiris P, Enekwe A, Nagarajah J, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 5. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Pratumvinit B, Sa-Nga-Areekul N.
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [Abstract] [Full Text] [Related]

  • 6. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Aug; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 7. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS, Coffler MS, Malcom PJ, Chang RJ.
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [Abstract] [Full Text] [Related]

  • 8. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 9. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 10. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov 01; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 11. The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome.
    Casadei L, Madrigale A, Puca F, Manicuti C, Emidi E, Piccione E, Dewailly D.
    Gynecol Endocrinol; 2013 Jun 01; 29(6):545-50. PubMed ID: 23506275
    [Abstract] [Full Text] [Related]

  • 12. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
    Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D.
    J Clin Endocrinol Metab; 2003 Dec 01; 88(12):5957-62. PubMed ID: 14671196
    [Abstract] [Full Text] [Related]

  • 13. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB, Vanky E, Carlsen SM.
    Hum Reprod; 2012 Aug 01; 27(8):2494-502. PubMed ID: 22693172
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.
    Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, Duhamel A, Catteau-Jonard S.
    Hum Reprod; 2011 Nov 01; 26(11):3123-9. PubMed ID: 21926054
    [Abstract] [Full Text] [Related]

  • 15. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
    Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC.
    J Clin Endocrinol Metab; 2004 Jan 01; 89(1):318-23. PubMed ID: 14715867
    [Abstract] [Full Text] [Related]

  • 16. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 Jan 01; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 17. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R.
    Fertil Steril; 2015 Feb 01; 103(2):537-41. PubMed ID: 25467043
    [Abstract] [Full Text] [Related]

  • 18. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, Duhamel A.
    J Clin Endocrinol Metab; 2010 Sep 01; 95(9):4399-405. PubMed ID: 20610596
    [Abstract] [Full Text] [Related]

  • 19. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug 01; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 20. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.